National Vaccine
Information Center

Your Health. Your Family. Your Choice.

MedAlerts Home
Search Results

This is VAERS ID 1408780

History of Changes from the VAERS Wayback Machine

First Appeared on 7/23/2021

VAERS ID: 1408780
VAERS Form:2
Age:
Sex:Female
Location:Foreign
Vaccinated:0000-00-00
Onset:2021-06-04
Submitted:0000-00-00
Entered:2021-06-17
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH FA1027 / 1 - / -

Administered by: Other      Purchased by: ??
Symptoms: Abdominal pain upper, Atrophic vulvovaginitis, Chest pain, Loss of libido, Palpitations, Sensory loss

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? Yes
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? No
ER or ED Visit (V2.0)? No
Hospitalized? No
Previous Vaccinations:
Other Medications: BOOTS ALLERGY RELIEF ANTIHISTAMINE; MAEXENI; PARACETAMOL
Current Illness:
Preexisting Conditions:
Allergies:
Diagnostic Lab Data:
CDC 'Split Type': GBPFIZER INC2021663807

Write-up: loss of sensation; Stomach pain; Lack of libido; Atrophy of vulva; Palpitations; Chest pain; This is a spontaneous report from a contactable consumer received from the Regulatory Agency. The regulatory authority report number is GB-MHRA-WEBCOVID-202106062104293270-6HRK8. An unspecified age female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: solution for injection, Batch/Lot Number: FA1027), via an unspecified route of administration on an unspecified date as 1ST dose, Single Dose for COVID-19 immunisation. The patient''s medical history was not reported. The patient has not had symptoms associated with covid-19, has not had a covid-19 test, and is not enrolled in a clinical trial. Concomitant medications included chlorpheniramine maleate (BOOTS ALLERGY RELIEF ANTIHISTAMINE), ethinylestradiol, levonorgestrel (MAEXENI) taken from 01Jan2019, and paracetamol for unspecified indications (start and stop date were not reported). on an unspecified date the patient experienced loss of sensation. On 04Jun2021, the patient experienced stomach pain, lack of libido, atrophy of vulva, palpitations, and chest pain. The seriousness criteria of the events were considered to be other medically important condition. The patient reported that stomach pain and palpitations occurred during the night and caused her to wake up and intermittent dull chest pain followed on her right side. The patient also reported complete loss of sensation in clitoris. The outcome of the event loss of sensation was unknown. The outcome of the events palpitations, chest pain and stomach pain was on 05Jun2021. The outcome of the event lack of libido and atrophy of vulva was 06Jun2021. No follow-up attempts are possible. No further information is expected.

New Search

Link To This Search Result:

https://medalerts.org/vaersdb/findfield.php?IDNUMBER=1408780&WAYBACKHISTORY=ON


Copyright © 2021 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166